Accrol Group Holdings PLC Director's Dealing (2216B)
29 Gennaio 2020 - 08:00AM
UK Regulatory
TIDMACRL
RNS Number : 2216B
Accrol Group Holdings PLC
29 January 2020
The information contained within this announcement is deemed by
the Company to constitute inside information stipulated under the
Market Abuse Regulation (EU) No. 596/2014. Upon the publication of
this announcement via the Regulatory Information Service, this
inside information is now considered to be in the public
domain.
29 January 2020
Accrol Group Holdings plc
(AIM: ACRL)
Director's Dealing
Accrol Group Holdings plc (the "Company" or "Accrol"), the
AIM-listed leading independent tissue converter, announces that,
Dan Wright, Executive Chairman of Accrol purchased 1,000,000
ordinary shares of GBP0.001 each ("Ordinary Shares") on 28 January
2020 at a price of 38.0p per Ordinary Share. Following this
purchase, he now holds 4,077,808 Ordinary Shares representing 2.09%
of the current Issued Share Capital of the Company.
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Dan Wright
--------------------------------- --------------------------------
2 Reason for the notification
-------------------------------------------------------------------
a) Position/status Executive Chairman
--------------------------------- --------------------------------
b) Initial notification Initial notification
/Amendment
--------------------------------- --------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Accrol Group Holdings plc
--------------------------------- --------------------------------
b) LEI 213800MC56M5G69RJ226
--------------------------------- --------------------------------
4 Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted
-------------------------------------------------------------------
a) Description Ordinary shares of GBP0.001
of the financial
instrument, ISIN: GB00BZ6VT592
type of instrument
Identification
code
--------------------------------- --------------------------------
b) Nature of the Purchase of Ordinary Shares
transaction
--------------------------------- --------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s)
38.0p 1,000,000
--------------------------------- ------------ ------------------
d) Aggregated information
- Aggregated N/A - single transaction
volume
- Price
--------------------------------- --------------------------------
e) Date of the 28 January 2020
transaction
--------------------------------- --------------------------------
f) Place of the London Stock Exchange, AIM
transaction
--------------------------------- --------------------------------
Enquiries:
For further information, please contact:
Accrol Group Holdings plc
Dan Wright, Executive Chairman +44 (0) 1254 278 844
Gareth Jenkins, Chief Executive Officer +44 (0) 1254 278 844
Zeus Capital Limited (Nominated Adviser
& Broker)
Dan Bate / Nick Cowles +44 (0) 161 831 1512
Dominic King / John Goold +44 (0) 203 829 5000
Belvedere Communications Limited
Cat Valentine (cvalentine@belvederepr.com) +44 (0) 7715 769 078
Keeley Clarke (kclarke@belvederepr.com) +44 (0) 7967 816 525
Llew Angus (langus@belvederepr.com) +44 (0) 7407 023 147
Notes to Editors
Accrol Group Holdings plc, based in Lancashire, is a leading
tissue converter and supplier of toilet rolls, kitchen rolls and
facial tissues, as well as other tissue products, to major
discounters and grocery retailers throughout the UK.
The business operates from four sites in Lancashire:
-- A manufacturing, storage and distribution facility in
Blackburn;
-- A storage and administrative centre in Blackburn;
-- A facial tissue plant, also in Blackburn; and
-- A manufacturing, storage and distribution facility in
Leyland.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBCGDBUDDDGGI
(END) Dow Jones Newswires
January 29, 2020 02:00 ET (07:00 GMT)
Grafico Azioni Accrol (LSE:ACRL)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Accrol (LSE:ACRL)
Storico
Da Mar 2023 a Mar 2024